Skip to main content

Year: 2021

Cabaletta Bio to Participate in Upcoming Investor Conferences in November

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that the Company will participate in two upcoming investor conferences in November:Guggenheim Securities 3rd Annual Neuro/Immunology Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat on Tuesday, November 16, 2021 at 8:15 a.m. ET. Members of management will also be available for one-on-one meetings.Evercore ISI 4th Annual HealthCONx Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat on Tuesday, November 30, 2021 at 12:35 p.m. ET. Members of management...

Continue reading

Streamline Health® To Participate in 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

Atlanta, GA, Nov. 09, 2021 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (Nasdaq: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and improve financial performance, has been invited to participate in the 12th Annual Craig-Hallum Alpha Select Conference, which is being held virtually on Tuesday, November 16, 2021. For additional information about the conference or to schedule a one-on-one meeting with Streamline Health management, please reach out to your Craig-Hallum representative or Streamline’s investor relations contact. About Streamline Streamline Health Solutions, Inc. is a leader in pre-bill revenue integrity solutions for healthcare providers. Our eValuator Revenue Integrity Program includes integrated solutions, technology-enabled services...

Continue reading

Cara Therapeutics to Present at Upcoming Investor Conferences

STAMFORD, Conn., Nov. 09, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announced that Christopher Posner, President and Chief Executive Officer, will participate in the following upcoming investor conferences in November: Stifel 2021 Virtual Healthcare Conference, November 15, 2021 – November 17, 2021Fireside Chat on Monday, November 15, 2021 at 1:20 p.m. ET Jefferies London Healthcare Conference, November 16, 2021 – November 19, 2021Fireside Chat on Thursday, November 18, 2021 at 3:00 a.m. ET Webcasts of the fireside chats can be accessed under “Events & Presentations” in the News & Investors section...

Continue reading

MeiraGTx to Participate in Upcoming Virtual Investor Conferences

LONDON and NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following virtual investor conferences:Barclays Gene Editing & Gene Therapy SummitCorporate presentation: Monday, November 15, 2021, at 2:00 p.m. ET33rd Annual Piper Sandler Healthcare ConferenceFireside chat: available from Monday, November 22, 2021, at 10:00 a.m. ET to Thursday, December 2, 2021 for registered attendees via the Piper Sandler conference site.Evercore ISI 4th Annual HealthCONxCorporate presentation: Tuesday, November 30, 2021, at 10:05 a.m. ET A live webcast of the corporate presentations and the recording of the Piper Sandler fireside...

Continue reading

AirBoss Announces Solid 3rd Quarter Results and Ongoing Momentum

NEWMARKET, Ontario, Nov. 09, 2021 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced its third quarter performance as it moves forward into the remainder of the year and 2022 with very strong momentum. The Company will host a conference call and webcast to discuss the results on November 10th at 9 a.m. ET, the details of which are further below. Recent Highlights ($US except where otherwise noted)Completed the acquisition of 100% ownership of Ace Elastomer, Inc. (“Ace”) for US$42.5 million in cash; Announced new credit facilities with increased revolving credit availability up to $250 million (from $150 million) with an accordion of $75 million (from $50 million); Received approval from the National Institute for Occupational Safety and Health (“NIOSH”) for its new...

Continue reading

Taboola Reports Strong Q3 Results and Raises Full Year 2021 Guidance

Company delivers strong growth and profitability to beat Q3 guidance Increases full year guidance across all key financial measures, expects to grow both Gross Profit and ex-TAC Gross Profit 34 to 35% for the full year 2021 Completed acquisition of Connexity on September 1, 2021NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, helping people discover things they may like, today announced its results for the quarter ended September 30, 2021. “The third quarter had some significant milestones for Taboola. It was our first quarter as a public company and we executed well, delivering results above our guidance while also closing our largest acquisition, Connexity, that gives us transformative e-commerce capabilities, growing our yield and revenue to...

Continue reading

Independence Holding Company Announces Definitive Acquisition Agreement

STAMFORD, Conn., Nov. 09, 2021 (GLOBE NEWSWIRE) — Independence Holding Company (NYSE: IHC) (the “Company”) today announced that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) to be acquired by Geneve Holdings, Inc. (the “Going Private Transaction”). Under the terms of the Merger Agreement, holders of the Company’s outstanding shares of common stock, excluding shares held by Geneve Holdings, Inc. and its wholly owned subsidiaries (collectively, “Geneve”), will receive $57.00 per share in cash. The $57.00 per share price represents a premium of 35.7% over $42.01 per share, the trading price for common stock on August 27, 2021, the trading date immediately preceding the date on which Geneve initially proposed to acquire the Company, and a premium of 15.2% over the closing trading price of $49.50...

Continue reading

Artisan Partners Asset Management Inc. Reports October 2021 Assets Under Management

MILWAUKEE, Nov. 09, 2021 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management (“AUM”) as of October 31, 2021 totaled $179.7 billion. Artisan Funds and Artisan Global Funds accounted for $88.4 billion of total firm AUM, while separate accounts and other AUM1 accounted for $91.3 billion.PRELIMINARY ASSETS UNDER MANAGEMENT BY STRATEGY2         As of October 31, 2021 – ($ Millions)    Growth Team    Global Opportunities $28,368    Global Discovery 2,326    U.S. Mid-Cap Growth 18,229    U.S. Small-Cap Growth 6,615    Global Equity Team    Global Equity 3,017    Non-U.S. Growth 21,813    Non-U.S. Small-Mid Growth 9,578    China Post-Venture 140    U.S. Value Team    Value Equity 4,009    U.S....

Continue reading

EDOC Acquisition Corp. Announces Sponsor Approval of Extension of Deadline to Complete Business Combination

Victor, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) — EDOC Acquisition Corp. (NASDAQ: ADOC) (the “Company”), a publicly traded special purpose acquisition company, announced today that its sponsor, American Physicians LLC (the “Sponsor”), has requested that the Company extend the date by which the Company has to consummate a business combination from November 12, 2021 to February 12, 2022 (the “Extension”). The Extension is the first of up to two three-month extensions permitted under the Company’s governing documents. In connection with such Extension, the Sponsor has notified the Company that it intends to cause an aggregate of $900,000 to be deposited into the Company’s trust account on or before November 12, 2021. About EDOC Acquisition Corp. Edoc Acquisition Corp. is a blank check company organized for the purpose of effecting a merger,...

Continue reading

Burlington Stores, Inc. Announces Third Quarter Fiscal Year 2021 Earnings Release Date, Conference Call and Webcast

BURLINGTON, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel at everyday low prices, will release its third quarter fiscal year 2021 results before the U.S. stock market opens on Tuesday, November 23, 2021. The Company will also hold a conference call to discuss results at 8:30 a.m. (Eastern Time) that day. The U.S. toll free dial-in for the conference call is 1-866-437-5084 (passcode: 1079197) and the international dial-in number is 1-409-220-9374. A live webcast of the conference call will also be available on the investor relations page of the company’s website at www.burlingtoninvestors.com. For those unable to participate in the conference call, a replay will be available after the conclusion of the call on November...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.